Led by the University of Oxford’s Professor Freddie Hamdy, and including researchers from three different countries, the team plans to distinguish between a lethal prostate cancer and one that doesn’t need treatment. They will combine detailed molecular analysis of existing samples with novel lines of investigation in new patient groups – aiming to understand what biological features are present at the earliest point when cancer spreads or becomes resistant to treatment.
Read more (Nuffield Department of Surgical Sciences website)